SPONSOR
BioNTech SE
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2, Phase 1
Conditions studied: Locally Advanced Breast CancerUnresectable Breast CarcinomaMetastatic Breast CancerAdvanced Solid TumorHIV -1 Infection
BioNTech SE is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer, Advanced Solid Tumor.
The trial portfolio spans Phase 1, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — BioNTech SE
How many clinical trials has BioNTech SE sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by BioNTech SE, of which 3 are actively recruiting participants. These trials cover conditions including Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does BioNTech SE research focus on?
BioNTech SE clinical trials span Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer, Advanced Solid Tumor, HIV -1 Infection. The research pipeline includes Phase 1, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a BioNTech SE clinical trial?
To participate in a BioNTech SE trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all BioNTech SE trials with current recruitment status updated daily.
Clinical Trials by BioNTech SE
NCT06827236 Phase 1, Phase 2
Recruiting
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Locally Advanced Breast Cancer
NCT06750185 Phase 1
Recruiting
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Advanced Solid Tumor
NCT07392372 Phase 1
Recruiting
A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV
HIV -1 Infection
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology